Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-026734

Options or other derivatives

  • General Counsel, Corporate Sec acquired 179,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Bryan E. General Counsel, Corporate Sec 2023-05-01 Grant or award · Stock Option (right to buy) +179,000 179,000 D: show line 1 in the form
Loading xslF345X04/doc4.xml…